These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 809046)

  • 21. [Effectiveness of Brinerdine in different hemodynamic types of arterial hypertension].
    Lapshina LA; Borovik IG; Chirkov SN; Dunaevskaia MM
    Ter Arkh; 1984; 56(4):83-6. PubMed ID: 6427965
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled clinical study of the blood pressure lowering effect of a rauwolfia-saluretic combination, with and without addition of an adrenolytic agent].
    Esch I; Wohlzogen FX; Scheiber V
    Wien Z Inn Med; 1971; 52(5):265-71. PubMed ID: 4999322
    [No Abstract]   [Full Text] [Related]  

  • 23. [The Kristepin and obzidan treatment of patients with hypertension].
    Leviashvili BI
    Vrach Delo; 1989 Jun; (6):39-40. PubMed ID: 2506697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of hypotensive drugs on plasma renin activity in primary hypertension].
    Zminkowska U
    Pol Tyg Lek; 1980 Aug; 35(33):1261-4. PubMed ID: 6776504
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modern therapy of the stabilization of essential hypertension by using a new drug combination: Bridina].
    Bernik V
    Hospital (Rio J); 1969 Aug; 76(2):589-99. PubMed ID: 4981741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with a new antihypertensive agent].
    Stampfer E
    Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618
    [No Abstract]   [Full Text] [Related]  

  • 27. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide].
    Martinetti L; Lai G
    Arch Maragliano Patol Clin; 1970; 26(3):209-18. PubMed ID: 5002193
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (preliminary communication)].
    Elizalde JE
    Hospital (Rio J); 1968 Dec; 74(6):2073-5. PubMed ID: 4977025
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of exercise stress by antihypertensive treatment with a combination containing beta-blocker/diuretic or reserpine.
    Lindner UK
    J Hum Hypertens; 1990 Aug; 4(4):445-9. PubMed ID: 1979634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of DCR-515 essental arterial hypertension of moderate severity(preliminary communition)].
    Vichi FL; da Silva EJ; Cesar EB; Machado RR; Gigante E
    Hospital (Rio J); 1969 Jul; 76(1):99-106. PubMed ID: 4981545
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (final communication)].
    Elizalde JE
    Hospital (Rio J); 1968 Dec; 74(6):2077-81. PubMed ID: 4977026
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Further clinico-therapeutic aspects of therapy of arterial hypertension].
    Anselmo B; Basso L
    Clin Ter; 1971 Jan; 56(1):55-70. PubMed ID: 5002870
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new effective antihypertensive agent. Studies on 40 patients].
    Bott H; Lill G
    Med Welt; 1968 Mar; 13():834-6. PubMed ID: 4974637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of late gestational toxicosis using Briserin].
    Weidinger H; Christner R
    Geburtshilfe Frauenheilkd; 1973 Jul; 33(7):586-91. PubMed ID: 4200218
    [No Abstract]   [Full Text] [Related]  

  • 40. [Design and evaluation of a clinical study comparing combinations of antihypertensive agents].
    Scheiber V; Wohlzogen FX; Esch I
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):346-51. PubMed ID: 4996196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.